Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for CANAGLIFLOZIN

Ingredient

CANAGLIFLOZIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
AURO-CANAGLIFLOZIN	100MG	TABLET	Actual shortage	2026-03-03	2026-03-09	279578
AURO-CANAGLIFLOZIN	300MG	TABLET	Actual shortage	2026-03-03	2026-03-09	279581
INVOKAMET	1000MG 50MG	TABLET	Avoided shortage	2023-07-24	2023-10-13	199842
INVOKAMET	1000MG 150MG	TABLET	Avoided shortage	2023-07-24	2023-10-13	199839
INVOKAMET	500MG 150MG	TABLET	Resolved	2019-06-26	2019-07-10	87506
INVOKAMET	500MG 150MG	TABLET	Avoided shortage	2023-07-24	2023-10-13	199845
JAMP CANAGLIFLOZIN	100MG	TABLET	Anticipated shortage	2026-03-10	2026-03-10	280179
JAMP CANAGLIFLOZIN	100MG	TABLET	Anticipated shortage	2026-03-10	2026-03-10	280182
JAMP CANAGLIFLOZIN	300MG	TABLET	Anticipated shortage	2026-03-10	2026-03-10	280187
JAMP CANAGLIFLOZIN	300MG	TABLET	Anticipated shortage	2026-03-10	2026-03-10	280190

1
2
Next

Showing 1 to 10 of 11

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
INVOKAMET	850MG 50MG	TABLET	To be discontinued	2018-01-24	2018-01-24	37086
INVOKAMET	500MG 150MG	TABLET	Discontinued	2024-06-18	2024-11-13	230850
INVOKAMET	850MG 150MG	TABLET	To be discontinued	2018-01-24	2018-01-24	37089

1

Showing 1 to 3 of 3